Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms
-
- Investigative and Clinical Urology
- /
- v.59 no.6
- /
- pp.399-409
- /
- 2018